Transcultural Validation of the Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) in French: The PASIPD-Fr (PASIPD-Fr)

The Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) is a scale that has been developped and validated in English to quantify the level of physical activity for people with physical disabilities. The investigators aimed to translate and validate a French transcultural version of the PASIPD (PASIPD-Fr) through a rigourous process following international recommendations for cross-cultural translation and adaptation of questionnaires.

Study Overview

• Status: Completed
• Conditions: Physical Disability; Neurological Diseases or Conditions
• Intervention / Treatment: Behavioral: PASIPD-Fr

Detailed Description

For the translation, permission to proceed was obtained, and translation was conducted in consultation with the developers. The investigators proceed to a first translation of the initial scale from English to French with two French native bilingual physicians that resulted in a unique french translation. An English native bilingual physicians proceeded to a back translation from French to English. This version have been sent to the developers who agreed that this back translated version was faithful to the original scale.

For the validation, the investigators used the international recommendations for cross-cultural translation and adaptation of questionnaires. Population was individuals with neurological disease (stroke, multiple sclerosis, Parkinson disease and neuromuscular disorders) with significant in physical disability. Patients were invited in an ambulatory setting. Data collected for every participant included demographic and general variables (age, sex, level, cause and time since neurological disease, walking capacities and aid), scores of a physical performance tests (10 Meter Walking Test, 10 MWT) and the 4 self-administered questionnaires: the Dijon Physical Activity Scale (PAS) the Activities-specific Balance Confidence (ABC) Scale, the Medical Outcome Study Short Form 12 " (MOS SF-12) and the Hospital Anxiety and Depression (HAD) scale.

Face validity was assessed using verbal feedbacks from physician and patients, and the mean time to fill-out the scale.

Criterion validity was assessed with correlation and discrimination analysis between the scores for the PASIPD-Fr and the Dijon PAS.

Construct validity was assessed using the correlation with scores of instruments that measure various aspects related to and physical activity (convergent validity) such as the self-reported questionaires ABC, SF-12 and HAD scales and also the 10 MWT.

For consistency and reliability, the investigators calculated the Cronbach α coefficient and calculated the ICC between 2 completions at a 2-week interval.

Sample calculation was based on an expected ICC > 0.9, which required 50 participants to reject the hypothesis that the actual ICC is < 0.6, which corresponds to the lower limit for a "good" reproducibility.

• Study Type: Interventional
• Enrollment (Actual): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Caen, France, 14000
    • CHU Caen Normandie

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Patient who received research information
• Patient affiliated to a social security system
• Patient over 18 years of age
• Patients with physical disabilities (Act No. 2005-102 on equal rights and opportunities)
• Individuals with the following disease: stroke survivors, multiple sclerosis, neuromuscular disease and idiopathic Parkinson's disease

Exclusion Criteria:

• Patient not affiliated to a social security system.
• Patients under guardianship or curators or protection of justice.
• Lack of informed information about the study
• Alteration of higher functions or sensory disturbance making it impossible to understand and adhere to the research protocol
• A severe medical condition that significantly alters functional abilities (severe heart failure, respiratory failure, unstable metabolic disorders such as active renal failure) and involves a life-threatening condition in the short to medium term (progressive neoplastic pathology, unstable systemic disease).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Participants; All the participants volunteer to participate to the study that were included.	Behavioral: PASIPD-Fr; Fill-out the PASIPD-Fr self questionaire twice (2 completions at a 2-week interval)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Criterion validity (correlation)	The Dijon PAS assesses the level of physical activity in the general population, the elderly and is recommended after a stroke. To test the criterion validity of the PASIPD-Fr, the investigators calculated the Pearson correlation coefficient (PCC) between the scores for the PASIPD-Fr and the Dijon PAS.	Both scales (PASIPD-Fr and Dijon PAS) were filled-out in a single point of time within a period of time of 12 months (study time frame)
Criterion validity (discrimination)	The Dijon PAS assesses the level of physical activity in the general population, the elderly and is recommended after a stroke. To test the criterion validity of the PASIPD-Fr, the investigators used the repeated measures ANOVA to check for differences between inactive, moderately active ang highly active individuals (respectively score <10, 10-20 and >20 over 30 on Dijon PAS) with Tukey post-hoc tests.	Both scales (PASIPD-Fr and Dijon PAS) were filled-out in a single point of time within a period of time of 12 months (study time frame)
Test-retest reliability	The investigators calculated the intraclass coefficient (ICC) between 2 completions of the PASIPD-Fr questionnaire at a 2-week interval.	The PASIPD-Fr was administered twice at a 2-week interval within a period of time of 12 months (study time frame)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Construct validity 10TMWT	The 10 Meter Walk Test is is a performance measure used to assess walking speed in metres per second over a short distance.To test the criterion validity of the PASIPD-Fr, the investigators calculated the Pearson correlation coefficient (PCC) between the scores for the PASIPD-Fr and the 10MWT	Both PASIPD-Fr questionaire and 10MWT test were assessed in a single point of time within a period of time of 12 months (study time frame)
Construct validity ABC-S	The Activities-specific balance confidence (ABC) scale is a subjective measure of confidence in performing various ambulatory activities without experiencing a sense of unsteadiness.To test the criterion validity of the PASIPD-Fr, the investigators calculated the Pearson correlation coefficient (PCC) between the scores for the PASIPD-Fr and the ABC-S	Both PASIPD-Fr questionaire and ABC-S scale were filled-out in a single point of time within a period of time of 12 months (study time frame)
Construct validity HAD	The Hospital Anxiety and Depression scale (HAD) is used to determine the levels of anxiety and depression that a person is experiencing. To test the criterion validity of the PASIPD-Fr, the investigators calculated the Pearson correlation coefficient (PCC) between the scores for the PASIPD-Fr and the HAD	Both PASIPD-Fr questionaire and HAD scale were filled-out in a single point of time within a period of time of 12 months (study time frame)
Construct validity MOS SF12	The Medical Outcome Study Short Form 12 " (MOS SF-12) is used to measure mental and physical health. To test the criterion validity of the PASIPD-Fr, the investigators calculated the Pearson correlation coefficient (PCC) between the scores for the PASIPD-Fr and the MOS SF12	Both PASIPD-Fr questionaire and MOS SF12 scale were filled-out in a single point of time within a period of time of 12 months (study time frame)
Internal consistency	To measure the internal consistency (homogeneity) of the PASIPD-Fr, based on average inter-item correlations and the number of items.	The PASIPD-Fr scale was filled-out in a single point of time within a period of time of 12 months (study time frame)

Collaborators and Investigators

• Sponsor: University Hospital, Caen

Publications and helpful links

General Publications

• Meunier P, Joussain C, Gremeaux V, Carnet D, Bastable P, Ruet A, Drigny J. Transcultural adaptation and validation of a French version of the Physical Activity Scale for Individuals with Physical Disabilities (PASIPD-Fr). Ann Phys Rehabil Med. 2021 Jul;64(4):101423. doi: 10.1016/j.rehab.2020.07.006. Epub 2020 Aug 26. No abstract available.

Study record dates

Study Major Dates

• Study Start (Actual): July 1, 2017
• Primary Completion (Actual): February 1, 2019
• Study Completion (Actual): August 1, 2019

Study Registration Dates

• First Submitted: August 16, 2019
• First Submitted That Met QC Criteria: August 16, 2019
• First Posted (Actual): August 20, 2019

Study Record Updates

• Last Update Posted (Actual): February 17, 2026
• Last Update Submitted That Met QC Criteria: February 13, 2026
• Last Verified: August 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases
• Other Study ID Numbers: PASIPD-Fr

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No